Dr. Sznol on the Multidisciplinary Management of Immunotherapy-Associated Toxicities in Melanoma
January 11th 2021
Mario Sznol, MD, Yale Cancer Center, discusses the multidisciplinary management of toxicities associated with immunotherapy in patients with melanoma.